CANNAPHARMARX, INC. Convertible Notes Payable
CANNAPHARMARX, INC. (CPMD) had Convertible Notes Payable of $1.02 million as of 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable › Notes Payable
us-gaap:ConvertibleNotesPayable · last filed 2026-08-18
- 2026-06-30: Convertible Notes Payable $1.02M.
- 2025-12-31: Convertible Notes Payable $1.02M; Convertible Notes Payable as first filed $318.80K.
- 2025-09-30: Convertible Notes Payable $1.02M.
- 2025-06-30: Convertible Notes Payable $1.30M.
| Period end | Convertible Notes Payable | Convertible Notes Payable as first filed |
|---|---|---|
| 2026-06-30 | $1.02M 10-Q · filed 2026-08-18 | |
| 2025-12-31 | $1.02M 10-Q · filed 2026-08-18 | $318.80K 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.02M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.30M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.30M 10-Q · filed 2025-05-16 | |
| 2024-12-31 | $407.51K 10-K · filed 2026-03-31 | $1.30M 10-K · filed 2025-04-10 |
| 2024-09-30 | $1.15M 10-Q · filed 2024-11-14 | |
| 2024-03-31 | $1.22M 10-Q · filed 2024-06-25 | |
| 2023-12-31 | $1.52M 10-K · filed 2025-04-10 | |
| 2023-09-30 | $1.38M 10-Q · filed 2023-11-17 | |
| 2023-06-30 | $1.38M 10-Q · filed 2023-10-13 | |
| 2023-03-31 | $1.34M 10-Q · filed 2023-09-22 | |
| 2022-12-31 | $1.14M 10-Q · filed 2023-11-17 | |
| 2021-12-31 | $775.45K 10-K · filed 2023-09-01 | |
| 2020-09-30 | $2.50M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $2.08M 10-Q · filed 2020-08-19 | |
| 2020-03-31 | $1.99M 10-Q · filed 2020-06-29 | |
| 2019-12-31 | $1.55M 10-Q · filed 2020-11-12 | |
| 2019-09-30 | $1.20M 10-Q · filed 2019-11-14 | |
| 2018-12-31 | $2.07M 10-K · filed 2020-05-27 |